Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04861701
Other study ID # YM109101E
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date June 30, 2021

Study information

Verified date May 2021
Source National Yang Ming University
Contact Mei-Wen Tsai, Ph. D
Phone +886+2+28267939
Email tmwk@ym.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the effect and predictors of static stretching exercise on hot flush in women after performing 4-week stretching exercises.


Description:

Hot flush (HF) is the most common symptom among menopausal syndrome and can significantly affect women's quality of life. Considering the risk of hormone therapy, the behavioral therapies have been proposed for the alternative treatment of HF. However, the exercise prescription for women with HF is controversial. Previous studies show the inconsistent effect of aerobic exercise on HF, and a moderate-to-high intensity exercise seems to aggravate HF frequency and severity. Recent studies have shown that static stretching exercise could improve HF in middle-aged women, but the related research is quite few, and the physiological mechanism as well as predictors for responders who can benefit from stretching exercise are still not clear. The knowledge of predictors for responders will provide clinicians and clients with HF symptoms to choose static stretching exercise as their treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date June 30, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: 1. Age between 20-65 years old. 2. With hot flashes. 3. No current therapies such as hormone therapy, psychotropic medications, or sleeping pills for the past 6 months. 4. With ability to follow instructions of stretching exercise. Exclusion Criteria: 1. SBP >160 mmHg or DBP >100 mmHg 2. Medical condition under investigation or unstable condition that could affect hot flashes, like thyroid disease. 3. Any medical condition limiting the ability to participate the exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Static stretching exercise
The intervention of this study is home-based stretching exercise. The experimental group will receive 6 stretching exercises which stretch 60 seconds for each side (left or right) of each movement, and relax for 10-20 seconds between the movements. It will take 10-15 minutes every day for continuous 4 weeks. The 6 stretching exercises include : (1) pectoral muscles + calf muscles ; (2) quadriceps ; (3) levator scapulae ; (4) gluteal muscles ; (5) hamstrings ; (6) trunk side-flexors.

Locations

Country Name City State
Taiwan National Yang Ming University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Yang Ming University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hot flush frequency Frequency of hot flush (time/day) pre-intervention
Primary Hot flush frequency Frequency of hot flush (time/day) week 1 of intervention period
Primary Hot flush frequency Frequency of hot flush (time/day) week 2 of intervention period
Primary Hot flush frequency Frequency of hot flush (time/day) week 3 of intervention period
Primary Hot flush frequency Frequency of hot flush (time/day) week 4 of intervention period (post-intervention)
Primary Hot flush score The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) pre-intervention
Primary Hot flush score The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) week 1 of intervention period
Primary Hot flush score The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) week 2 of intervention period
Primary Hot flush score The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) week 3 of intervention period
Primary Hot flush score The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) week 4 of intervention period (post-intervention)
Secondary Standard deviation of NN intervals (SDNN) SDNN represents total heart rate variability. (unit: ms) pre-intervention
Secondary Standard deviation of NN intervals (SDNN) SDNN represents total heart rate variability. (unit: ms) week 4 of intervention period (post-intervention)
Secondary Absolute total power Absolute total power represents total activity of autonomic nervous system. (unit: ms^2) pre-intervention
Secondary Absolute total power Absolute total power represents total activity of autonomic nervous system. (unit: ms^2) week 4 of intervention period (post-intervention)
Secondary Low frequency in normalized unit (LF norm) LF norm represents sympathetic nerve activity. pre-intervention
Secondary Low frequency in normalized unit (LF norm) LF norm represents sympathetic nerve activity. week 4 of intervention period (post-intervention)
Secondary High frequency in normalized unit (HF norm) HF norm represents parasympathetic nerve activity. pre-intervention
Secondary High frequency in normalized unit (HF norm) HF norm represents parasympathetic nerve activity. week 4 of intervention period (post-intervention)
Secondary Percentage of low frequency (LF%) LF% represents sympathetic nerve activity. pre-intervention
Secondary Percentage of low frequency (LF%) LF% represents sympathetic nerve activity. week 4 of intervention period (post-intervention)
Secondary Percentage of high frequency (HF%) HF% represents parasympathetic nerve activity. pre-intervention
Secondary Percentage of high frequency (HF%) HF% represents parasympathetic nerve activity. week 4 of intervention period (post-intervention)
Secondary LF/HF ratio (L/H ratio) L/H ratio represents autonomic nerve balance. pre-intervention
Secondary LF/HF ratio (L/H ratio) L/H ratio represents autonomic nerve balance. week 4 of intervention period (post-intervention)
Secondary Muscle flexibility of upper extremities Apley's scratch test (unit: cm) pre-intervention
Secondary Muscle flexibility of upper extremities Apley's scratch test (unit: cm) week 4 of intervention period (post-intervention)
Secondary Muscle flexibility of lower extremities Sit-and-reach test (unit: cm) pre-intervention
Secondary Muscle flexibility of lower extremities Sit-and-reach test (unit: cm) week 4 of intervention period (post-intervention)
Secondary Vascular endothelial function Reflective index (RI) (unit:%) pre-intervention
Secondary Vascular endothelial function Reflective index (RI) (unit:%) week 4 of intervention period (post-intervention)
Secondary Hot Flush Related Daily Interference Scale (HFRDIS) Hot Flush Related Daily Interference Scale (HFRDIS), minimum value : 0, maximum value : 100, higher scores mean a worse outcome pre-intervention
Secondary Hot Flush Related Daily Interference Scale (HFRDIS) Hot Flush Related Daily Interference Scale (HFRDIS), minimum value : 0, maximum value : 100, higher scores mean a worse outcome week 4 of intervention period (post-intervention)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04587154 - Womens Study to Alleviate Vasomotor Symptoms N/A
Terminated NCT03642119 - Validation of an Objective Instrument to Measure Hot Flashes During Menopause
Completed NCT05061563 - A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults Phase 1
Completed NCT05419908 - Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes Phase 2
Completed NCT01281332 - Mechanical Device for the Relief of Hot Flashes Phase 2
Completed NCT01439945 - Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer Phase 2
Completed NCT00755417 - Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women Phase 3
Completed NCT01293695 - Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial N/A
Completed NCT00599456 - Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women. N/A
Completed NCT00256685 - Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause Phase 3
Completed NCT00391417 - Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms Phase 3
Terminated NCT00244894 - Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer N/A
Completed NCT00010712 - Effects of Black Cohosh on Menopausal Hot Flashes Phase 2
Active, not recruiting NCT03580499 - Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy N/A
Recruiting NCT06030388 - Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women N/A
Recruiting NCT04418115 - Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option? N/A
Active, not recruiting NCT05086705 - EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer N/A
Completed NCT05099159 - A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) Phase 3
Completed NCT01140646 - Evaluation of SAMe for Hot Flashes Phase 2
Completed NCT00956813 - Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy Phase 3